3rd Quarter - Report

FEDERAL STREET STRATEGIES, LLC for ABBVIE, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient access to drug treatment therapies; and drug cost and drug pricing reform efforts. H.R. 3 - Lower Drug Costs Now Act of 2019 S.2543, Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor.
DERRON PARKS New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 3 (116th)

Medicare/Medicaid MMM

Medicare Part D policies. H.R. 3 - Lower Drug Costs Now Act of 2019 S.2543, Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor.
DERRON PARKS New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2543 (116th), H.R. 3 (116th)

Medical/Disease Research/Clinical Labs MED

Transparency of prescription drug pricing; and patient costs of prescription drugs. H.R. 3 - Lower Drug Costs Now Act of 2019 S.2543, Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor.
DERRON PARKS New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.